Glycome remodeling programs pathogenic γδ T17 cell responses in autoimmunity
Authors:
- Beatriz Santos-PereiraBSBeatriz Santos-Pereira
- Rafaela NogueiraRNRafaela Nogueira
- Yohannes TafesseYTYohannes Tafesse
- Ariana Correia-SilvaACAriana Correia-Silva
- Eduarda Leite-GomesELEduarda Leite-Gomes
- Guillem Sanchez SanchezGSGuillem Sanchez Sanchez
- Xavier LuppensXLXavier Luppens
- Lyndsay E.A. YoungLYLyndsay E.A. Young
- Carlos VasconcelosCVCarlos Vasconcelos
- Daniela OliveiraDODaniela Oliveira
- Ana LéALAna Lé
- 16 October 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 11 (124) , eaec9553
Abstract
Glycans play fundamental roles in T cell biology; however, the glycome landscape of γδ T cells remains to be unlocked. Despite the growing importance of γδ T cells in host defense, tissue homeostasis, and diseases, the glycosylation mechanisms guiding their activation, commitment, and function remain poorly defined. By performing single-cell RNA sequencing, we revealed that type 3/γδ T17/interleukin-17A (IL-17A)–committed γδ T cells rely on ( N-acetylglucosaminyltransferase 1 ) MGAT1 – MGAT5 –mediated branched N-glycosylation. We further demonstrated that the absence of branched N -glycans on γδ T cells acts as a peripheral signal, driving an IL-17A–pro-inflammatory phenotype, alongside a shift to a Vγ4 + subset and the imprinting of innate-like properties. This altered glycoform of type 3 γδ T cells was shown to induce severe psoriasis. γδ T cells from patients with autoimmune and inflammatory diseases exhibited a deficiency in branched N -glycans. Glycan supplementation can reprogram γδ T cells toward a less-pathogenic state, highlighting N -glycans as a previously unrecognized immune checkpoint for γδ T cells.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK123704)
- H2020 European Research Council (GlycanSwitch (101071386))
- H2020 European Research Council (PhD Fellowship in the GlycanSwitch project)
- Lupus Research Alliance (LRA 2022 Innovation grant)
- Fundação para a Ciência e a Tecnologia (2023.16654.ICDT)
- Fundação para a Ciência e a Tecnologia (2022.00337.CEECIND)
- European Society for Clinical Investigation (Exploratory Research Grant 2024)
- European Federation of Immunological Societies (Short-term Fellowship)
- Fundação para a Ciência e a Tecnologia (UI/BD/151550/2021)
- Université Libre de Bruxelles (WELBIO-CR-2022A)
- European Union (GlycanTrigger (101093997))
- Fundação para a Ciência e Tecnologia (UI/BD/152866/2022)
This publication has 77 references indexed in Scilit:
- Maternal Administration of Probiotics Augments IL17‐Committed γδ T Cells in the Newborn LungEuropean Journal of Immunology, 2025
- Metformin suppresses gammadelta T17 cell differentiation alleviating DSS-induced colitisImmunologic Research, 2025
- Modulation of Plet1 expression by N-Acetylglucosamine through the IL-17 A-MAPK pathway in an imiquimod-induced psoriasis mouse modelInflammation Research, 2024
- Glycans as a key factor in self and nonself discrimination: impact on the breach of immune toleranceFEBS Letters, 2022
- Protein Mannosylation as a Diagnostic and Prognostic Biomarker of Lupus Nephritis: An Unusual Glycan Neoepitope in Systemic Lupus ErythematosusArthritis & Rheumatology, 2021
- TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasisEuropean Journal of Immunology, 2013
- Enrichment of circulating interleukin‐17–secreting interleukin‐23 receptor–positive γ/δ T cells in patients with active ankylosing spondylitisArthritis & Rheumatism, 2011
- CCR6 and NK1.1 distinguish between IL‐17A and IFN‐γ‐producing γδ effector T cellsEuropean Journal of Immunology, 2009
- Complex N-Glycan Number and Degree of Branching Cooperate to Regulate Cell Proliferation and DifferentiationCell, 2007
- γδ T Cells Express Activation Markers in the Central Nervous System of Mice with Chronic-relapsing Experimental Autoimmune EncephalomyelitisJournal of Autoimmunity, 2001